Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement

Keyphrases

• Consensus Statement 100%
• Postoperative Management 100%
• Cardiovascular Medications 100%
• Perioperative Assessment 100%
• Hypertension 50%
• Cardiovascular Disease 50%
• Internal Medicine 50%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 50%
• Anesthesiology 50%
• Vasodilator 50%
• Beta-blockers 50%
• Sodium 50%
• Phosphodiesterase Type 5 Inhibitors 50%
• Angiotensin 50%
• Heart Failure 50%
• Anesthesia 50%
• Endothelin Receptor Antagonist 50%
• Calcium Channel Blockers 50%
• Perioperative Care 50%
• Preoperative Evaluation 50%
• Potassium Channel Openers 50%
• Potassium-sparing Diuretics 50%
• Angiotensin Receptor Blockers 50%
• Loop Diuretics 50%
• Perioperative Management 50%
• Arrhythmia 50%
• Adrenergic Receptor Antagonist 50%
• Adrenoceptors 50%
• Medication Management 50%
• Sodium Channel Blocker 50%
• Direct-acting 50%
• Evidence-based Recommendations 50%
• Modified Delphi Method 50%
• Antiarrhythmic Agents 50%
• Cardiac Glycosides 50%
• Thiazide Diuretics 50%
• Preoperative Medication 50%
• Renin-angiotensin System Inhibitors 50%
• Class I Antiarrhythmics 50%
• Sympatholytics 50%
• Specialty Societies 50%
• Class III Antiarrhythmic Agents 50%

Medicine and Dentistry

• Cardiovascular System 100%
• Quality Improvement 100%
• Adrenergic Receptor Blocking Agent 100%
• Antiarrhythmic Agent 100%
• Internal Medicine 50%
• ACE Inhibitor 50%
• Clinician 50%
• Anesthesiology 50%
• Calcium Channel Blocking Agent 50%
• Angiotensin 50%
• Adrenergic Receptor 50%
• Preoperative Evaluation 50%
• Potassium Channel Opener 50%
• Congestive Heart Failure 50%
• Potassium Sparing Diuretic Agent 50%
• Loop Diuretic Agent 50%
• Cardiac Dysrhythmia 50%
• Angiotensin Receptor Antagonist 50%
• Thiazide Diuretic Agent 50%
• Phosphodiesterase V Inhibitor 50%
• Endothelin Receptor Antagonist 50%
• Cardiovascular Condition 50%
• Perioperative Medicine 50%
• Cardiac Glycoside 50%
• Renin Inhibitor 50%
• Sodium Channel Blocker 50%
• Diuretics 50%